Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sign Test for Matched Pairs01:17

Sign Test for Matched Pairs

419
The sign test for matched pairs offers a robust method for comparing two paired samples, often for the effects of an intervention in one of them. This method is very useful in situations where the underlying distribution of the data is unknown. The test compares two related samples—often pre- and post-treatment measurements on the same subjects—to determine if there are significant differences in their median values.
To conduct the sign test, we first calculate the differences in...
419
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.6K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.6K
Wilcoxon Signed-Ranks Test for Matched Pairs01:09

Wilcoxon Signed-Ranks Test for Matched Pairs

501
The Wilcoxon signed-rank test for matched pairs evaluates the null hypothesis by combining the ranks of differences with their signs. It essentially tests whether the median of the differences in a population of matched pairs is zero. Since the test incorporates more information than the sign test, it generally yields more trustable conclusions. This test also does not require the data to follow a normal distribution, but two conditions must be met for it to be applicable: (1) the data must...
501
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

506
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
506
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19-Associated Portal Vein Thrombosis Post-Cholecystitis.

The International journal of angiology : official publication of the International College of Angiology, Inc·2023
Same author

Hematologic Conditions: Leukopenia.

FP essentials·2019
Same author

Hematologic Conditions: Leukocytosis and Leukemia.

FP essentials·2019
Same author

Hematologic Conditions: Common Hemoglobinopathies.

FP essentials·2019
Same author

Hematologic Conditions: Platelet Disorders.

FP essentials·2019

Related Experiment Video

Updated: Feb 8, 2026

Minimal Erythema Dose MED Testing
06:24

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

42.9K

Diabetes in the elderly: Matching meds to needs.

Barbara Keber1, Jennifer Fiebert1

  • 1Hofstra Northwell School of Medicine, Northwell Health, Glen Cove, NY, USA.

The Journal of Family Practice
|July 11, 2018
PubMed
Summary

Elderly patients with insulin resistance need personalized treatment. Age-related decline in beta-cell function and other diseases complicate management, requiring tailored therapeutic approaches.

Area of Science:

  • Gerontology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Insulin resistance is a significant metabolic challenge in elderly individuals.
  • Age-related decline in pancreatic beta-cell function exacerbates insulin resistance.
  • Concomitant diseases in older adults further complicate metabolic management.

Purpose of the Study:

  • To highlight the complex therapeutic considerations for elderly patients with insulin resistance.
  • To emphasize the need for personalized treatment strategies in this demographic.

Main Methods:

  • This study synthesizes current research on insulin resistance in aging.
  • It reviews the impact of age-related physiological changes on glucose metabolism.
  • It considers the influence of comorbidities on treatment efficacy.

More Related Videos

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

9.2K
Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
10:43

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice

Published on: October 31, 2007

28.9K

Related Experiment Videos

Last Updated: Feb 8, 2026

Minimal Erythema Dose MED Testing
06:24

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

42.9K
Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

9.2K
Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
10:43

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice

Published on: October 31, 2007

28.9K

Main Results:

  • Elderly patients present unique challenges due to combined insulin resistance and reduced beta-cell reserve.
  • Age-related factors and comorbidities necessitate individualized treatment plans.
  • Standard treatment protocols may not be optimal for older adults.

Conclusions:

  • Personalized therapeutic strategies are essential for managing insulin resistance in the elderly.
  • A comprehensive approach considering age-related changes and comorbidities is crucial for effective treatment.